Torrent Pharma Q3FY19

1. Profit surges to Rs 246 cr v/s Rs 58 cr
2. Revenue rises 40.2% to Rs 2,051 cr v/s Rs 1,463 cr YoY.
3. Board approved issuance of unsecured / secured redeemable non-convertible debentures / bonds by way of private placement within the borrowing limits of the company.